Back to search
FDAFDA · Food and drugs·Recall number D-0012-2015

All sterile products within expiry

Published October 15, 2014 · Recall initiated: July 18, 2014

Summary

FDA records drug Class II recall D-0012-2015, published October 15, 2014 and initiated July 18, 2014. Recalling firm: Unique Pharmaceutical, Ltd; Status: Terminated; Reported quantity: 325,225 units (syringes, vials, bags); Lot: All Lots. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Sterility Assurance: A recent FDA inspection revealed poor aseptic production practices that result in lack of sterility assurance of products intended to be sterile.

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Unique Pharmaceutical, Ltd
Distributor
Nationwide
Lot
All Lots
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was All sterile products within expiry recalled?

Yes. FDA published recall D-0012-2015 on October 15, 2014. Reported hazard: Lack of Sterility Assurance: A recent FDA inspection revealed poor aseptic production practices that result in lack of sterility assurance of products intended to be sterile.

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit